rxstat › Shortages › Hydrocortisone
Hydrocortisone shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Hydrocortisone products are in shortage in Canada (3 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Feb 29, 2016
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageHYDROCORTISONE SODIUM SUCCINATE FOR INJECTION
100MG · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 00872520 · since Feb 29, 2016, no end estimate · Disruption of the manufacture of the drug.
Active shortageHYDROCORTISONE SODIUM SUCCINATE FOR INJECTION
250MG · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 00872539 · since Feb 29, 2016, no end estimate · Disruption of the manufacture of the drug.
Active shortageHYDROCORTISONE SODIUM SUCCINATE FOR INJECTION
500MG · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 00878618 · since Feb 29, 2016, no end estimate · Disruption of the manufacture of the drug.
ResolvedAURO-HYDROCORTISONE
10MG · TABLET · AURO PHARMA INC
DIN 02524465 · ended Apr 21, 2026 · Demand increase for the drug.
ResolvedAURO-HYDROCORTISONE
10MG · TABLET · AURO PHARMA INC
DIN 02524465 · ended Apr 21, 2026 · Delay in shipping of the drug.
ResolvedAURO-HYDROCORTISONE
20MG · TABLET · AURO PHARMA INC
DIN 02524473 · ended Apr 20, 2026 · Demand increase for the drug.
ResolvedAURO-HYDROCORTISONE
20MG · TABLET · AURO PHARMA INC
DIN 02524473 · ended Apr 6, 2026 · Delay in shipping of the drug.
ResolvedSOLU-CORTEF
100MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 00030600 · ended Mar 2, 2026 · Disruption of the manufacture of the drug.
ResolvedSOLU-CORTEF
100MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 00030600 · ended Aug 27, 2025 · Disruption of the manufacture of the drug.
DiscontinuedSANDOZ HYDROCORTISONE
2.5% · CREAM · SANDOZ CANADA INCORPORATED
DIN 02469421
ResolvedSANDOZ HYDROCORTISONE
2.5% · CREAM · SANDOZ CANADA INCORPORATED
DIN 02469421 · ended Apr 1, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ HYDROCORTISONE
2.5% · CREAM · SANDOZ CANADA INCORPORATED
DIN 02469421 · ended Dec 9, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 59 reports. All reports are on file with Health Canada.
What's happening
Hydrocortisone is currently affected by 3 active shortage reports filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Hydrocortisone is classified under “CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN” (ATC H02AB).
Recent changes
Common questions
When will Hydrocortisone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Hydrocortisone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.